US FDA’s Confidence In Gene Editing Safety Growing Enough That Regulatory Bar May Be Lowered

Peter Marks (third from left) at the NORD Breakthrough Summit
CBER Director Peter Marks (third from left) speaks about gene therapy during the NORD Breakthrough Summit. • Source: National Organization for Rare Disorders (NORD)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies